| |
| |
|
| Insider
Information: |
Johnson James A |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
13,548 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,479 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,548 |
|
|
| Total
Value |
$2,479 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zymogenetics Inc |
ZGEN |
Executive VP and CFO |
2010-10-08 |
0 |
2004-06-29 |
0 |
Premium* |
|
|
Nanostring Technologies Inc |
NSTG |
Chief Financial Officer |
2017-09-01 |
8,548 |
2014-03-03 |
0 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director |
2023-03-29 |
5,000 |
2023-03-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHA |
Athira Pharma, Inc. |
Director |
– • – |
2023-03-29 |
4 |
B |
$2.40 |
$12,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2017-09-01 |
4 |
A |
$13.20 |
$7,841 |
D/D |
594 |
8,548 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2017-03-01 |
4 |
A |
$12.16 |
$7,548 |
D/D |
621 |
7,954 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2017-02-06 |
4 |
D |
$18.80 |
$20,473 |
D/D |
(1,089) |
7,333 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2017-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
8,422 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2016-11-11 |
4 |
AS |
$22.60 |
$99,237 |
D/D |
(4,391) |
5,089 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2016-11-11 |
4 |
OE |
$5.12 |
$22,482 |
D/D |
4,391 |
9,480 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2016-11-10 |
4 |
OE |
$5.12 |
$28,718 |
D/D |
5,609 |
10,698 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2016-11-10 |
4 |
AS |
$22.46 |
$126,418 |
D/D |
(5,609) |
5,089 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2016-09-01 |
4 |
A |
$12.16 |
$7,539 |
D/D |
620 |
5,089 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2016-03-01 |
4 |
A |
$9.52 |
$7,235 |
D/D |
760 |
4,469 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2015-09-01 |
4 |
A |
$9.52 |
$7,245 |
D/D |
761 |
3,709 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2015-03-02 |
4 |
A |
$9.52 |
$7,511 |
D/D |
789 |
2,948 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2014-09-02 |
4 |
A |
$6.62 |
$7,039 |
D/D |
1,063 |
2,159 |
0 |
- |
|
| NSTG |
Nanostring Technologies I... |
Chief Financial Officer |
• – – |
2014-03-03 |
4 |
A |
$6.62 |
$7,257 |
D/D |
1,096 |
1,096 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2010-10-08 |
4 |
D |
$9.75 |
$253,685 |
D/D |
(26,019) |
0 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2010-09-08 |
4 |
S |
$9.75 |
$195,000 |
D/D |
(20,000) |
26,019 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2010-09-08 |
4 |
OE |
$2.78 |
$55,540 |
D/D |
20,000 |
46,019 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2009-12-07 |
4 |
S |
$7.00 |
$70,000 |
D/D |
(10,000) |
26,019 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2009-12-07 |
4 |
OE |
$2.78 |
$27,777 |
D/D |
10,000 |
36,019 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2009-08-31 |
4 |
S |
$6.00 |
$60,000 |
D/D |
(10,000) |
26,019 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2009-08-31 |
4 |
OE |
$2.78 |
$27,777 |
D/D |
10,000 |
36,019 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Executive VP and CFO |
• – – |
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
100 |
26,019 |
0 |
- |
|
| ZGEN |
Zymogenetics Inc |
Senior Vice President and CFO |
• – – |
2006-08-24 |
4 |
AS |
$20.04 |
$60,120 |
D/D |
(3,000) |
25,919 |
|
- |
|
| ZGEN |
Zymogenetics Inc |
Senior VP and CFO |
• – – |
2006-03-13 |
4 |
S |
$21.75 |
$65,250 |
D/D |
(3,000) |
28,919 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
